このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

シミュレートされた熱波中の高齢者の生理学的ひずみに対する屋内湿度の影響

2026年11月9日 更新者:Glen P. Kenny、University of Ottawa

推奨される屋内温度の調整は、より高いレベルの湿度中に必要な26°Cの上限が必要ですか?

Laboratory-based studies show that exposure to high humidity can worsen the effects of heat stress in young and older adults by impeding sweat evaporation - the main mechanism by which the human body cools itself. At high levels of humidity, the efficiency of sweating decreases causing a greater rise core temperature and burden on the cardiovascular system. In this context, increasing temperatures and humidity with climate change thus pose a potential compound risk for human health. While humidity's role in heat-health outcomes could substantially alter projections of health burdens from climate change, the impact of humidity on physiological strain in vulnerable people in relation to the indoor environment has yet to be evaluated. In a recent study delineating the physiological effects of the proposed 26°C indoor upper limit (PMID: 38329752), relative humidity was set to 45% in all conditions based on indoor humidity standards by the American Society of Heating and Air-Conditioning Engineers. However, it is unknown whether a refinement of the recommended indoor temperature limit of 26°C is required in situations where humidity cannot be maintained at this level.

On separate occasions, the investigators will assess the change in body temperature and cardiovascular strain in older adults (65-85 years) exposed for 10 hours at the recommended indoor temperature limit of 26°C and 45% relative humidity (equivalent humidex of 29 (considered comfortable)) (experimental condition A), to 26°C with a relative humidity of 15% (equivalent humidex of 23 (considered comfortable); humidex is used to measure the perceived temperature taking into account the humidity)) (experimental condition B), to 26°C with a relative humidity of 85% (equivalent humidex of 37 (considered somewhat uncomfortable)) (experimental condition C), and to 31°C and 45% relative humidity with an equivalent humidex of 37 (considered somewhat uncomfortable) that is similar to experimental condition C. With this experimental design, investigators will assess the effects of indoor humidity in driving human heat strain and identify whether refinements in the recommended 26°C indoor temperature limit may be required. Further, by evaluating changes in relation to ambient conditions with a similar humidex, the investigators can assess how individuals perceive and respond to both heat and humidity.

調査の概要

状態

積極的、募集していない

研究の種類

介入

入学 (推定)

10

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Ontario
      • Ottawa、Ontario、カナダ、K1N6N5
        • University of Ottawa

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

60年~85年 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Non-smoking.
  • English or French speaking.
  • Ability to provide informed consent.
  • with or without a) chronic hypertension (elevated resting blood pressure; as defined by Heart and Stroke Canada and Hypertension Canada), b) type 2 diabetes as defined by Diabetes Canada, with at least 5 years having elapsed since time of diagnosis

Exclusion Criteria:

  • Episode(s) of severe hypoglycemia (requiring the assistance of another person) within the previous year, or inability to sense hypoglycemia (hypoglycemia unawareness).
  • Serious complications related to diabetes (gastroparesis, renal disease, uncontrolled hypertension, severe autonomic neuropathy).
  • Uncontrolled hypertension - BP >150 mmHg systolic or >95 mmHg diastolic in a sitting position.
  • Restrictions in physical activity due to disease (e.g. intermittent claudication, renal impairment, active proliferative retinopathy, unstable cardiac or pulmonary disease, disabling stroke, severe arthritis, etc.).
  • Use of or changes in medication judged by the patient or investigators to make participation in this study inadvisable.
  • Cardiac abnormalities identified during screening

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Exposure to recommended indoor temperature limit with normal indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 26°C and 45% relative humidity (humidex equivalent of 29).

Older adults are exposed to a 10-hour simulated exposure

実験的:Exposure to recommended indoor temperature limit with low indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 26°C and 15% relative humidity (humidex equivalent of 23).

Older adults are exposed to a 10-hour simulated exposure

実験的:Exposure to recommended indoor temperature limit with high indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 26°C and 85% relative humidity (humidex equivalent of 37).

Older adults are exposed to a 10-hour simulated exposure

実験的:Exposure to high indoor temperature with normal indoor humidity

Participants exposed daylong (10 hours) to an indoor temperature maintained at 31°C and 45% relative humidity (humidex equivalent of 37).

Older adults are exposed to a 10-hour simulated exposure

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Core temperature (Peak) during daylong exposure to indoor overheating
時間枠:End of 10 hour daylong exposure

Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout the 10 hours of the simulated indoor overheating.

End of 10 hour daylong exposure
Core temperature (AUC) during daylong exposure to indoor overheating
時間枠:End of 10 hour daylong exposure

Areas under the curve (AUC) of rectal temperature during the 10 hour simulate indoor overheating.

End of 10 hour daylong exposure
Heat rate (Peak) during daylong exposure to indoor overheating
時間枠:End of 10 hour daylong exposure

Peak heart rate (15 min average) during exposure. Heart rate is measured continuously throughout the 10 hours of the simulated indoor overheating.

End of 10 hour daylong exposure
Heart rate (AUC) during daylong exposure to indoor overheating
時間枠:End of 10 hour daylong exposure

Areas under the curve (AUC) of heart rate during the 10 hour simulate indoor overheating.

End of 10 hour daylong exposure
Cardiac response to standing from supine (30:15 Ratio) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Systolic Response to Standing From Supine during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Heart rate variability: RMSSD during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the supine position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Heart rate variability: SDNN during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the supine position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of supine rest).

At the start (hour 0) and end of 10 hour daylong exposure
Thermal comfort scale during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Thermal comfort assessed via a visual analog scale ranging from extremely uncomfortable to extremely comfortable (midpoint: neutral).

At the start (hour 0) and end of 10 hour daylong exposure
Thirst sensation scale during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Thermal sensation assessed via a visual analog scale ranging from extremely hot to neutral (midpoint: hot).

At the start (hour 0) and end of 10 hour daylong exposure
Arousal scale during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Felt arousal scale assessed via a visual analog scale ("How worked up are you?") ranging from "high arousal" to "low arousal".

At the start (hour 0) and end of 10 hour daylong exposure
Fluid loss during daylong exposure to indoor overheating
時間枠:At end of 10 hour daylong exposure

Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).

At end of 10 hour daylong exposure
Changes in plasma volume during daylong exposure to indoor overheating
時間枠:At end of 10 hour daylong exposur

Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill

At end of 10 hour daylong exposur
Systolic blood pressure during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

At the start (hour 0) and end of 10 hour daylong exposure
Rate pressure product during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.

At the start (hour 0) and end of 10 hour daylong exposure

二次結果の測定

結果測定
メジャーの説明
時間枠
Impulse control (cognitive function) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device.

At the start (hour 0) and end of 10 hour daylong exposure
Memory recall (cognitive function) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test.

At the start (hour 0) and end of 10 hour daylong exposure
CDC 4-Stage Balance Test (Postural stability) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc).

At the start (hour 0) and end of 10 hour daylong exposure
BTrackS Balance Assessment (Postural stability) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

To assess postural stability, participants will be asked to stand on a BTracks force plate with their feet spread out to shoulder width, hand on their hips and eyes closed. The assessment will comprise of four trials (one practice trial) lasting 20 seconds in length and 20 seconds between trials. Center of pressure (COP) vector data along vertical (y) and horizontal (x) axes will be summed for the total path excursion length (cm) during each trial.

At the start (hour 0) and end of 10 hour daylong exposure
Profiles of Mood States (POMS) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem-related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives (reference). For each individual item, participants were asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) were summed to calculate its score.

At the start (hour 0) and end of 10 hour daylong exposure
Environmental Symptoms Questionnaire (ESQ) during daylong exposure to indoor overheating
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure [24, 25]. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score was calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake").

At the start (hour 0) and end of 10 hour daylong exposure
Sleepiness during daylong exposure to indoor overheating A
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Karolinska sleepiness scale measures the subjective level of sleepiness at a particular time

At the start (hour 0) and end of 10 hour daylong exposure
Sleepiness during daylong exposure to indoor overheating B
時間枠:At the start (hour 0) and end of 10 hour daylong exposure

Stanford sleepiness scale consists of only one item, where participant must identify one of seven statements that best represents their level of perceived sleepiness. It employs a scale of 1 to 7 with 1 = feeling wide awake and 7 = sleep onset soon

At the start (hour 0) and end of 10 hour daylong exposure

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年3月14日

一次修了 (実際)

2025年11月20日

研究の完了 (推定)

2027年9月1日

試験登録日

最初に提出

2025年2月17日

QC基準を満たした最初の提出物

2025年2月17日

最初の投稿 (実際)

2025年2月24日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月12日

QC基準を満たした最後の更新が送信されました

2026年11月9日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する